• Users Online: 119
  • Print this page
  • Email this page

    Article Cited by others

ORIGINAL ARTICLE

Secukinumab efficacy and safety in indian patients with moderate-to-severe plaque psoriasis: Sub-analysis from FIXTURE, a randomized, placebo-controlled, phase 3 study

Bhat Ramesh M, Leelavathy B, Aradhya Sacchidanand S, Gopal Maragondanahalli G, Pratap D. V. S., Mubashir Mir, Srinivas Putta, Pande Sushil Y, Thavkar Amit S

Year : 2017| Volume: 8| Issue : 1 | Page no: 16-24

   This article has been cited by
 
1 Effects of etanercept on the patient-perceived results (PROs) in patients with moderate-to-severe plaque psoriasis: systematic review of the literature and meta-analysis
Jose Manuel Carrascosa,Francisco Rebollo,Susana Gómez,Plablo De-la-Cueva
Journal of Dermatological Treatment. 2018; : 1
[Pubmed]  [Google Scholar] [DOI]
2 Raising Standards for the Evaluation of Future Psoriasis Therapeutics: A Critical Checklist
Zenas Z.N. Yiu,Richard B. Warren
Clinical Pharmacology & Therapeutics. 2017; 102(4): 642
[Pubmed]  [Google Scholar] [DOI]
3 Update on IL-17 Inhibitors for Psoriasis
Adriane A Levin,Jeffrey M Sobell
Current Dermatology Reports. 2017;
[Pubmed]  [Google Scholar] [DOI]

 

Read this article